Published 2014
| Version v1
Publication
MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: yes.
Creators
Contributors
Others:
Additional details
Identifiers
- URL
- http://hdl.handle.net/11567/772561
- URN
- urn:oai:iris.unige.it:11567/772561
Origin repository
- Origin repository
- UNIGE